Hospital
Banner Goldfield Medical Center
Banner Goldfield Medical Center was paid $18.63M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99285, emergency room visit (most serious) — 26% of everything it billed.
33Billing provider infoBANNER GOLDFIELD MEDICAL CENTER
APACHE JUNCTION, AZ 85120
APACHE JUNCTION, AZ 85120
33aNPI1932543428assigned 04/26/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.63M
24GClaims327,549
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arizona
Rank by total paid#31 of 78
Median peer was paid$12.21M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 49,030 | $3.03M | |
| 2019 | 45,585 | $2.88M | |
| 2020 | 37,063 | $2.35M | |
| 2021 | 45,652 | $2.54M | |
| 2022 | 54,164 | $2.94M | |
| 2023 | 51,284 | $2.68M | |
| 2024incomplete | 44,771 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26% | 11,245 | 10,127 | $4.87M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 17,090 | 15,739 | $4.71M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 17,000 | 15,902 | $4.06M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 2,855 | 2,692 | $2.08M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.3% | 2,082 | 1,934 | $982K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.8% | 6,209 | 5,851 | $902K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 3,040 | 2,854 | $436K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.2% | 202 | 185 | $220K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 624 | 585 | $153K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 250 | 242 | $84K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 856 | 649 | $35K |
| 70496 | <1% | 26 | 26 | $19K |
120 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,959 | $13K |
| 93971 | <1% | 197 | $10K | |
| 80320 | <1% | 2,856 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,704 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,074 | $5K |
| J3490 | Unclassified drugs | <1% | 9,427 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 19,761 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,095 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,682 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,686 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,150 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,002 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 3,183 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 197 | $1K |
| 87631 | <1% | 593 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,620 | $1K |
| 83690 | <1% | 8,326 | $777.86 | |
| 84484 | <1% | 7,531 | $583.25 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,634 | $574.74 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 627 | $561.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,436 | $440.11 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,142 | $395.36 |
| 96376 | <1% | 2,470 | $383.69 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,152 | $381.37 |
| 73130 | <1% | 758 | $370.84 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,259 | $333.13 |
| 81025 | <1% | 3,836 | $330.73 | |
| 12001 | <1% | 58 | $292.70 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 596 | $285.07 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,194 | $275.13 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 401 | $275.00 |
| 81001 | <1% | 7,771 | $272.38 | |
| 84703 | <1% | 711 | $267.99 | |
| 73562 | <1% | 629 | $266.86 | |
| 73630 | <1% | 830 | $248.32 | |
| 87077 | <1% | 1,961 | $241.84 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,481 | $229.38 |
| 72100 | <1% | 25 | $221.31 | |
| 87040 | <1% | 3,287 | $212.99 | |
| A9270 | Non-covered item or service | <1% | 8,093 | $162.84 |
| 73030 | <1% | 366 | $159.89 | |
| 83880 | <1% | 1,098 | $147.48 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,740 | $133.92 |
| 83735 | <1% | 4,099 | $125.37 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 312 | $110.81 |
| 83605 | <1% | 3,833 | $106.70 | |
| 90715 | <1% | 459 | $95.28 | |
| 73610 | <1% | 531 | $81.73 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,218 | $76.58 |
| 82947 | <1% | 3,052 | $65.56 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 11,269 | $63.12 |
| 87088 | <1% | 3,876 | $62.57 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 7,066 | $53.32 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 812 | $51.31 |
| 84702 | <1% | 1,216 | $49.95 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,280 | $47.88 |
| 73110 | <1% | 189 | $45.69 | |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 1,897 | $44.97 |
| 81003 | <1% | 3,254 | $44.22 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,822 | $43.02 |
| 85610 | <1% | 2,715 | $34.73 | |
| 82803 | <1% | 96 | $33.98 | |
| 82550 | <1% | 974 | $32.97 | |
| 87186 | <1% | 1,501 | $31.15 | |
| 87081 | <1% | 295 | $29.23 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 920 | $27.24 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,278 | $25.96 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 577 | $25.32 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,341 | $15.95 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 486 | $12.61 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,246 | $12.49 |
| 86850 | <1% | 71 | $11.85 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 610 | $10.55 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 531 | $8.92 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 761 | $7.58 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 61 | $7.50 |
| 85379 | <1% | 383 | $7.33 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 890 | $6.93 |
| 85730 | <1% | 698 | $6.67 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 460 | $5.84 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,103 | $5.82 |
| 86901 | <1% | 333 | $5.29 | |
| 86900 | <1% | 173 | $5.22 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 32 | $4.90 |
| 86140 | <1% | 478 | $4.60 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 591 | $1.80 |
| 93976 | 0% | 309 | $0.00 | |
| 96367 | 0% | 377 | $0.00 | |
| 84100 | 0% | 149 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 52 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 69 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 93 | $0.00 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 27 | $0.00 |
| 74018 | 0% | 64 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 156 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 41 | $0.00 |
| 85055 | 0% | 32 | $0.00 | |
| 73080 | 0% | 13 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 12 | $0.00 |
| 87210 | 0% | 26 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 13 | $0.00 |
| 82010 | 0% | 16 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 140 | $0.00 |
| 51702 | 0% | 15 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 37 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 108 | $0.00 |
| 87807 | 0% | 28 | $0.00 | |
| 85027 | 0% | 470 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 64 | $0.00 |
| 80329 | 0% | 356 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 496 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 158 | $0.00 |
| 73502 | 0% | 16 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 59 | $0.00 |
| 70498 | 0% | 26 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 93 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 16 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 45 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 90 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKELLAR, BRIAN (CEO)
Parent organizationBANNER HEALTH
| Provider | Location | Paid |
|---|---|---|
| Banner Baywood Medical Center | Mesa, AZ | $29.69M |
| Banner Ironwood Medical Center | Queen Creek, AZ | $29.40M |
| Banner Heart Hospital | Mesa, AZ | $340K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.